4.7 Review

Environmental factors in the pathogenesis of primary Sjogren's syndrome

期刊

JOURNAL OF INTERNAL MEDICINE
卷 287, 期 5, 页码 475-492

出版社

WILEY
DOI: 10.1111/joim.13032

关键词

infection; Sjogren's syndrome; smoking; SSA; SSB

资金

  1. Swedish Research Council
  2. Heart-Lung Foundation
  3. Stockholm County Council
  4. Karolinska Institute
  5. Swedish Rheumatism Association
  6. King Gustaf the V:th 80-year Foundation

向作者/读者索取更多资源

Primary Sjogren's syndrome (SS) is a systemic autoimmune disease in which exocrine organs, primarily the salivary and lacrimal glands, are targets of chronic inflammation, leading to severe dryness of eyes and mouth. Fatigue and arthralgia are also common, and extraglandular manifestations involving the respiratory, nervous and vascular systems occur in a subset of patients. Persistent activation of the type I interferon system, and autoreactive B and T cells with production of disease-associated autoantibodies are central to the pathogenesis. Genetic polymorphisms that associate with an increased risk of SS have been described, though the risk-increase contributed by the respective variant is generally low. It is thus becoming increasingly clear that genetics cannot alone account for the development of SS and that other, presumably exogenous, factors must play a critical role. Relatively few studies have investigated exposure to potential risk factors prior to SS disease onset. Rather, many factors have been studied in prevalent cases. In this review, we summarize current literature on exogenous factors in the pathogenesis of SS including infections, hormones, smoking, solvents and additional compounds. We delineate for which factors there is current evidence of increased disease risk, and for which our present knowledge is confined to suggesting their role in SS pathogenesis. Finally, we outline future perspectives in the continued search for environmental risk factors for SS, a research area of great importance considering the possibilities for preventive measures.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Rheumatology

Auxilin is a novel susceptibility gene for congenital heart block which directly impacts fetal heart function

Sabrina Meisgen, Malin Hedlund, Aurelie Ambrosi, Lasse Folkersen, Vijole Ottosson, David Forsberg, Gudny Ella Thorlacius, Luca Biavati, Linn Strandberg, Johannes Mofors, Daniel Ramskold, Sabrina Ruhrmann, Lauro Meneghel, William Nyberg, Alexander Espinosa, Robert Murray Hamilton, Anders Franco-Cereceda, Anders Hamsten, Tomas Olsson, Lois Greene, Per Eriksson, Kristina Gemzell-Danielsson, Stina Salomonsson, Vijay K. Kuchroo, Eric Herlenius, Ingrid Kockum, Sven-Erik Sonesson, Marie Wahren-Herlenius

Summary: This study identifies DNAJC6 as a novel genetic susceptibility factor in NLE, modulating cardiac function and providing new insights into the development of screening and therapeutic strategies for CHB.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Article Rheumatology

Complement C4 Copy Number Variation is Linked to SSA/Ro and SSB/La Autoantibodies in Systemic Inflammatory Autoimmune Diseases

Christian Lundtoft, Pascal Pucholt, Myriam Martin, Matteo Bianchi, Emeli Lundstrom, Maija-Leena Eloranta, Johanna K. Sandling, Christopher Sjowall, Andreas Jonsen, Iva Gunnarsson, Solbritt Rantapaa-Dahlqvist, Anders A. Bengtsson, Dag Leonard, Eva Baecklund, Roland Jonsson, Daniel Hammenfors, Helena Forsblad-d'Elia, Per Eriksson, Thomas Mandl, Sara Magnusson Bucher, Katrine B. Norheim, Svein Joar Auglaend Johnsen, Roald Omdal, Marika Kvarnstrom, Marie Wahren-Herlenius, Antonella Notarnicola, Helena Andersson, Oyvind Molberg, Louise Pyndt Diederichsen, Jonas Almlof, Ann-Christine Syvanen, Sergey Kozyrev, Kerstin Lindblad-Toh, Bo Nilsson, Anna M. Blom, Ingrid E. Lundberg, Gunnel Nordmark, Lina Marcela Diaz-Gallo, Elisabet Svenungsson, Lars Ronnblom

Summary: Copy number variation of C4A is associated with the autoimmune repertoire in systemic autoimmune diseases, with a low C4A copy number strongly linked to the presence of autoantibodies. These findings have implications for understanding the mechanisms of autoimmune diseases and patient stratification based on genetic profiles.

ARTHRITIS & RHEUMATOLOGY (2022)

Article Immunology

Autoantigenic properties of the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies

Charlotta Preger, Antonella Notarnicola, Cecilia Hellstrom, Edvard Wigren, Catia Fernandes-Cerqueira, Marika Kvarnstrom, Marie Wahren-Herlenius, Helena Idborg, Ingrid E. Lundberg, Helena Persson, Susanne Graslund, Per-Johan Jakobsson

Summary: This study identified new potential autoantigens among human cytoplasmic aminoacyl tRNA synthetases in IIM patients, even those previously classified as seronegative. These new autoantibodies have high clinical relevance and may provide insights into the pathogenesis of idiopathic inflammatory myopathies.

JOURNAL OF AUTOIMMUNITY (2023)

Article Rheumatology

2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice

Javier Rodriguez-Carrio, Agata Burska, Philip G. Conaghan, Willem A. Dik, Robert Biesen, Maija-Leena Eloranta, Giulio Cavalli, Marianne Visser, Dimitrios T. Boumpas, George Bertsias, Marie Wahren-Herlenius, Jan Rehwinkel, Marie-Louise Fremond, Mary K. Crow, Lars Ronnblom, Marjan A. Versnel, Edward M. Vital

Summary: This study developed evidence-based points to consider for the measurement and reporting of IFN-I assays in clinical research. The study provides recommendations on terminology, assay characteristics, and reporting practices, as well as explores the clinical applications of IFN-I assays in diagnosis and outcome assessments.

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Immunology

Immunology of pregnancy and reproductive health in autoimmune rheumatic diseases. Update from the 11th International Conference on Reproduction, Pregnancy and Rheumatic Diseases

Laura Andreoli, Cecilia B. Chighizola, Luca Iaccarino, Angela Botta, Maria Gerosa, Veronique Ramoni, Chiara Tani, Bonnie Bermas, Antonio Brucato, Jill Buyon, Irene Cetin, Christina D. Chambers, Megan E. B. Clowse, Nathalie Costedoat-Chalumeau, Maurizio Cutolo, Sara De Carolis, Radboud Dolhain, Elisa M. Fazzi, Frauke Foerger, Ian Giles, Isabell Haase, Munther Khamashta, Roger A. Levy, Pier Luigi Meroni, Marta Mosca, Catherine Nelson-Piercy, Luigi Raio, Jane Salmon, Peter Villiger, Marie Wahren-Herlenius, Marianne Wallenius, Cristina Zanardini, Yehuda Shoenfeld, Angela Tincani

Summary: Autoimmune rheumatic diseases (ARD) pose challenges to reproductive health. Preconception counseling should consider factors such as fertility, disease impact on pregnancy outcomes, disease activity during pregnancy, medication compatibility, and biomarkers predictive of adverse pregnancy outcomes (APO). Diseases like preeclampsia and pregnancy-induced hypertension are more likely to occur in women with ARD. Placental insufficiency can result in restricted fetal growth. Treatment with compatible drugs is essential for maternal and fetal wellbeing. While limited data is available on medication usage during pregnancy, TNF inhibitors are recommended. Non-medical issues like sexual dysfunction and long-term outcomes of children also require attention in this review. Collaborative research and pregnancy registries will contribute to future insights.

AUTOIMMUNITY REVIEWS (2023)

Review Rheumatology

Genetics and epigenetics of primary Sjogren syndrome: implications for future therapies

Gudny Ella Thorlacius, Albin Bjork, Marie Wahren-Herlenius

Summary: In primary Sjogren syndrome (pSS), chronic inflammation of exocrine glands leads to tissue destruction and sicca symptoms, mainly affecting the mouth and eyes. Fatigue, arthralgia, and myalgia are common, and some patients also experience extraglandular manifestations involving the respiratory, nervous, and vascular systems. The disease primarily affects women, with a female to male ratio of 14 to 1. The genetic and epigenetic studies have provided insights into the dysregulated molecular mechanisms of pSS and could potentially lead to new therapeutic options.

NATURE REVIEWS RHEUMATOLOGY (2023)

Review Rheumatology

Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider

Agata Burska, Javier Rodriguez-Carrio, Robert Biesen, Willem A. Dik, Maija-Leena Eloranta, Giulio Cavalli, Marianne Visser, Dimitrios T. Boumpas, George Bertsias, Marie Wahren-Herlenius, Jan Rehwinkel, Marie-Louise Fremond, Mary K. Crow, Lars Ronnblom, P. G. Conaghan, Marjan Versnel, Ed Vital

Summary: This study systematically reviewed the literature on assay methods for evaluating type I interferon (IFN-I) pathway activation and aimed to harmonize related terminology. Data from 276 papers on 412 methods were extracted and summarized. Consensus terminology was developed to define different aspects of IFN-I research and practice.

RMD OPEN (2023)

Review Rheumatology

Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider

Javier Rodriguez-Carrio, Agata Burska, P. G. Conaghan, Willem A. Dik, Robert Biesen, Maija-Leena Eloranta, Giulio Cavalli, Marianne Visser, Dimitrios T. Boumpas, George Bertsias, Marie Wahren-Herlenius, Jan Rehwinkel, Marie-Louise Fremond, Mary K. Crow, Lars Ronnblom, Ed Vital, Marjan Versnel

Summary: This article provides a systematic review of assays measuring IFN-I pathway activation and summarizes the potential clinical utility in various rheumatic and musculoskeletal diseases. The results show that IFN-I pathway activation is associated with disease diagnosis, disease activity assessment, prognosis, response to treatment, and assay responsiveness. However, the heterogeneity in techniques and technical conditions are major limitations.

RMD OPEN (2023)

Meeting Abstract Rheumatology

ANTI-FHL1 AUTOANTIBODIES IN ADULT MYOSITIS PATIENTS: BASELINE AND LONGITUDINAL FOLLOW-UP ANALYSIS

Angeles S. Galindo-Feria, Karin Lodin, Begum Horuluoglu, Sepehr Sarrafzadeh-Zargar, Edvard Wigren, Susanne Graslund, Olof Danielsson, Aladdin J. Mohammad, Dag Leonard, Christopher Sjowall, Thomas Husmark, Malin Hemberg, Silva Puksic, Theodoros Lappas, Balsam Hanna, Marie Wahren-Herlenius, Maryam Dastmalchi, Ingrid E. Lundberg

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (2023)

Meeting Abstract Rheumatology

FINE MAPPING OF THE DDX6-CXCR5 RISK INTERVAL REVEALS SNPS IN SJOGREN'S DISEASE WITH FUNCTIONAL SIGNIFICANCE IN IMMUNE CELLS AND SALIVARY GLAND

M. Wiley, B. Khatri, K. Tessneer, M. Joachims, A. Stolarczyk, A. Nagel, A. Rasmussen, S. J. Bowman, L. Radfar, R. Omdal, M. Wahren-Herlenius, B. Warner, T. Witte, R. Jonsson, M. Rischmueller, P. Gaffney, J. A. James, L. Ronnblom, R. H. Scofield, X. Mariette, W. F. Ng, K. Sivils, G. Nordmark, B. Tsao, C. J. Lessard

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (2022)

Meeting Abstract Rheumatology

Autophagy-related Risk Loci in Systemic Lupus Erythematous and Sjogren's Disease

Anna Nagel, Bhuwan Khatri, Marcin Radziszewski, Mandi Wiley, Anna Stolarczyk, Michelle Joachims, Kandice Tessneer, Astrid Rasmussen, Simon Bowman, Lida Radfar, Roald Omdal, Marie Wahren-Herlenius, Blake Warner, Torsten Witte, Roland Jonsson, Maureen Rischmueller, Patrick Gaffney, Judith James, Lars Ronnblom, Hal Scofield, Xavier Mariette, Marta Alarcon-Riquelme, Fai Ng, Gunnel Nordmark, Qing Sun, Kwangwoo Kim, Sang-Cheol Bae, Betty Tsao, A. Darise Farris, Christopher Lessard

ARTHRITIS & RHEUMATOLOGY (2022)

Meeting Abstract Rheumatology

Fetal Cardiac Targets Identify the Autoantibodies Associated with Congenital Heart Block

Stephanie Benjamin, Lisa Vi, Diptendu Chatterjee, Edgar Jaeggi, Marie Wahren-Herlenius, Amelia Ruffatti, Linda Hiraki, Michelle Lohbihler, Lusia Sepiashvili, Carl Laskin, Meena Fatah, Daniela Dominguez, Lawrence Ng, Anthony Gramolini, Vincent Christoffels, Stephanie Protze, Robert Hamilton

ARTHRITIS & RHEUMATOLOGY (2022)

Meeting Abstract Rheumatology

Transcriptome-Wide Association Study of Sjogren's Disease Risk Alleles Identifies Novel Genes with Altered Expression in Minor Salivary Gland and Other Tissues

Marcin Radziszewski, Mandi Wiley, Bhuwan Khatri, Kandice Tessneer, Astrid Rasmussen, Simon Bowman, Lida Radfar, Roald Omdal, Marie Wahren-Herlenius, Blake Warner, Torsten Witte, Roland Jonsson, Maureen Rischmueller, Patrick Gaffney, Judith James, Lars Ronnblom, R. Hal Scofield, Xavier Mariette, Marta Alarcon-Riquelme, Fai Ng, Gunnel Nordmark, Umesh Deshmukh, A. Darise Farris, Christopher Lessard

ARTHRITIS & RHEUMATOLOGY (2022)

Meeting Abstract Rheumatology

Fine Mapping of the Sjogren's Disease and Systemic Lupus Erythematosus DDX6-CXCR5 Risk Interval Reveals Common SNPs with Functional Significance in Immune and Salivary Gland Cells

Mandi Wiley, Bhuwan Khatri, Kandice Tessneer, Michelle Joachims, Anna Stolarczyk, Anna Nagel, Astrid Rasmussen, Simon Bowman, Lida Radfar, Roald Omdal, Marie Wahren-Herlenius, Blake Warner, Torsten Witte, Roland Jonsson, Maureen Rischmueller, Patrick Gaffney, Judith James, Lars Ronnblom, Hal Scofield, Xavier Mariette, Fai Ng, Gunnel Nordmark, Betty Tsao, Christopher Lessard

ARTHRITIS & RHEUMATOLOGY (2022)

Meeting Abstract Dermatology

SKIN INFILTRATING NK CELLS IN PRIMARY CUTANEOUS T-CELL LYMPHOMA ARE INCREASED IN NUMBER AND HAVE AN ALTERED PHENOTYPE PARTLY INDUCED BY THE LYMPHOMA

Andrea Scheffschick, Julia Nenonen, Anna Winther, Marcus Ehrstrom, Marie Wahren-Herlenius, Liv Eidsmo, Hanna Brauner

ACTA DERMATO-VENEREOLOGICA (2022)

暂无数据